Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4199111000168116 | Aprepitant (Apotex) (aprepitant 165 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4199121000168111 | Aprepitant (Apotex) 165 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aprepitant (Apotex) 165 mg capsule | Is a | aprepitant 165 mg capsule | true | Inferred relationship | Some | ||
| Aprepitant (Apotex) 165 mg capsule | Is a | Aprepitant (Apotex) | true | Inferred relationship | Some | ||
| Aprepitant (Apotex) 165 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Aprepitant (Apotex) 165 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Aprepitant (Apotex) 165 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 1250442323 | |
| Aprepitant (Apotex) 165 mg capsule | has Australian BoSS | aprepitant | true | Inferred relationship | Some | 1250442322 | |
| Aprepitant (Apotex) 165 mg capsule | has intended active ingredient | aprepitant | true | Inferred relationship | Some | 1250442322 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aprepitant (Apotex) 165 mg capsule, 1 | has TPUU | True | Aprepitant (Apotex) 165 mg capsule | Inferred relationship | Some | 1 |
| Aprepitant (Apotex) 165 mg capsule, 1, blister pack | has TPUU | True | Aprepitant (Apotex) 165 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR